Cargando…

Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model

BACKGROUND: To compare nondestructive in vivo and ex vivo micro-computed tomography (μCT) and ex vivo dual-energy-X-ray-absorptiometry (DXA) in characterizing mineralized cortical and trabecular bone response to prostate cancer involving the skeleton in a mouse model. METHODOLOGY/PRINCIPAL FINDINGS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravoori, Murali, Czaplinska, Aneta J., Sikes, Charles, Han, Lin, Johnson, Evan M., Qiao, Wei, Ng, Chaan, Cody, Dianna D., Murphy, William A., Do, Kim-Anh, Navone, Nora M., Kundra, Vikas
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847943/
https://www.ncbi.nlm.nih.gov/pubmed/20360964
http://dx.doi.org/10.1371/journal.pone.0009854
_version_ 1782179613807476736
author Ravoori, Murali
Czaplinska, Aneta J.
Sikes, Charles
Han, Lin
Johnson, Evan M.
Qiao, Wei
Ng, Chaan
Cody, Dianna D.
Murphy, William A.
Do, Kim-Anh
Navone, Nora M.
Kundra, Vikas
author_facet Ravoori, Murali
Czaplinska, Aneta J.
Sikes, Charles
Han, Lin
Johnson, Evan M.
Qiao, Wei
Ng, Chaan
Cody, Dianna D.
Murphy, William A.
Do, Kim-Anh
Navone, Nora M.
Kundra, Vikas
author_sort Ravoori, Murali
collection PubMed
description BACKGROUND: To compare nondestructive in vivo and ex vivo micro-computed tomography (μCT) and ex vivo dual-energy-X-ray-absorptiometry (DXA) in characterizing mineralized cortical and trabecular bone response to prostate cancer involving the skeleton in a mouse model. METHODOLOGY/PRINCIPAL FINDINGS: In vivo μCT was performed before and 10 weeks after implantation of human prostate cancer cells (MDA-PCa-2b) or vehicle into SCID mouse femora. After resection, femora were imaged by nondestructive ex vivo specimen μCT at three voxel sizes (31 µ, 16 µ, 8 µ) and DXA, and then sectioned for histomorphometric analysis of mineralized bone. Bone mineral density (BMD), trabecular parameters (number, TbN; separation, TbSp; thickness, TbTh) and mineralized bone volume/total bone volume (BV/TV) were compared and correlated among imaging methods and histomorphometry. Statistical tests were considered significant if P<0.05. Ten weeks post inoculation, diaphyseal BMD increased in the femur with tumor compared to the opposite femur by all modalities (p<0.005, n = 11). Diaphyseal BMD by in vivo μCT correlated with ex vivo 31 and 16 µm μCT and histomorphometry BV/TV (r = 0.91–0.94, P<0.001, n = 11). DXA BMD correlated less with bone histomorphometry (r = 0.73, P<0.001, n = 11) and DXA did not distinguish trabeculae from cortex. By in vivo and ex vivo μCT, trabecular BMD decreased (P<0.05, n = 11) as opposed to the cortex. Unlike BMD, trabecular morphologic parameters were threshold-dependent and when using “fixed-optimal-thresholds,” all except TbTh demonstrated trabecular loss with tumor and correlated with histomorphometry (r = 0.73–0.90, P<0.05, n = 11). CONCLUSIONS/SIGNIFICANCE: Prostate cancer involving the skeleton can elicit a host bone response that differentially affects the cortex compared to trabeculae and that can be quantified noninvasively in vivo and nondestructively ex vivo.
format Text
id pubmed-2847943
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-28479432010-04-01 Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model Ravoori, Murali Czaplinska, Aneta J. Sikes, Charles Han, Lin Johnson, Evan M. Qiao, Wei Ng, Chaan Cody, Dianna D. Murphy, William A. Do, Kim-Anh Navone, Nora M. Kundra, Vikas PLoS One Research Article BACKGROUND: To compare nondestructive in vivo and ex vivo micro-computed tomography (μCT) and ex vivo dual-energy-X-ray-absorptiometry (DXA) in characterizing mineralized cortical and trabecular bone response to prostate cancer involving the skeleton in a mouse model. METHODOLOGY/PRINCIPAL FINDINGS: In vivo μCT was performed before and 10 weeks after implantation of human prostate cancer cells (MDA-PCa-2b) or vehicle into SCID mouse femora. After resection, femora were imaged by nondestructive ex vivo specimen μCT at three voxel sizes (31 µ, 16 µ, 8 µ) and DXA, and then sectioned for histomorphometric analysis of mineralized bone. Bone mineral density (BMD), trabecular parameters (number, TbN; separation, TbSp; thickness, TbTh) and mineralized bone volume/total bone volume (BV/TV) were compared and correlated among imaging methods and histomorphometry. Statistical tests were considered significant if P<0.05. Ten weeks post inoculation, diaphyseal BMD increased in the femur with tumor compared to the opposite femur by all modalities (p<0.005, n = 11). Diaphyseal BMD by in vivo μCT correlated with ex vivo 31 and 16 µm μCT and histomorphometry BV/TV (r = 0.91–0.94, P<0.001, n = 11). DXA BMD correlated less with bone histomorphometry (r = 0.73, P<0.001, n = 11) and DXA did not distinguish trabeculae from cortex. By in vivo and ex vivo μCT, trabecular BMD decreased (P<0.05, n = 11) as opposed to the cortex. Unlike BMD, trabecular morphologic parameters were threshold-dependent and when using “fixed-optimal-thresholds,” all except TbTh demonstrated trabecular loss with tumor and correlated with histomorphometry (r = 0.73–0.90, P<0.05, n = 11). CONCLUSIONS/SIGNIFICANCE: Prostate cancer involving the skeleton can elicit a host bone response that differentially affects the cortex compared to trabeculae and that can be quantified noninvasively in vivo and nondestructively ex vivo. Public Library of Science 2010-03-29 /pmc/articles/PMC2847943/ /pubmed/20360964 http://dx.doi.org/10.1371/journal.pone.0009854 Text en Ravoori et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ravoori, Murali
Czaplinska, Aneta J.
Sikes, Charles
Han, Lin
Johnson, Evan M.
Qiao, Wei
Ng, Chaan
Cody, Dianna D.
Murphy, William A.
Do, Kim-Anh
Navone, Nora M.
Kundra, Vikas
Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model
title Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model
title_full Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model
title_fullStr Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model
title_full_unstemmed Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model
title_short Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model
title_sort quantification of mineralized bone response to prostate cancer by noninvasive in vivo μct and non-destructive ex vivo μct and dxa in a mouse model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847943/
https://www.ncbi.nlm.nih.gov/pubmed/20360964
http://dx.doi.org/10.1371/journal.pone.0009854
work_keys_str_mv AT ravoorimurali quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT czaplinskaanetaj quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT sikescharles quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT hanlin quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT johnsonevanm quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT qiaowei quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT ngchaan quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT codydiannad quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT murphywilliama quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT dokimanh quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT navonenoram quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel
AT kundravikas quantificationofmineralizedboneresponsetoprostatecancerbynoninvasiveinvivomctandnondestructiveexvivomctanddxainamousemodel